Wuhan Thalys Med Tech Co Ltd (603716) — Cash Flow Reinvestment Rate
Wuhan Thalys Med Tech Co Ltd (603716) has a Cash Flow Reinvestment Rate of 0.03x as of September 2025, reinvesting CN¥1.57 Million (capex CN¥1.57 Million ) from operating cash flow of CN¥54.57 Million. See Wuhan Thalys Med Tech Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wuhan Thalys Med Tech Co Ltd Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Wuhan Thalys Med Tech Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Wuhan Thalys Med Tech Co Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Wuhan Thalys Med Tech Co Ltd (2012–2024)
Year-by-year capital reinvestment analysis for Wuhan Thalys Med Tech Co Ltd. See Wuhan Thalys Med Tech Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.51x | CN¥50.33 Million | CN¥99.60 Million | CN¥23.21 Million | ▲ +41.5% |
| 2023 | 0.36x | CN¥44.94 Million | CN¥125.89 Million | CN¥40.83 Million | ▼ -87.5% |
| 2022 | 2.85x | CN¥80.02 Million | CN¥28.12 Million | CN¥54.64 Million | ▼ -90.3% |
| 2020 | 29.43x | CN¥292.68 Million | CN¥9.94 Million | CN¥127.70 Million | ▲ +1449.0% |
| 2019 | 1.90x | CN¥178.47 Million | CN¥93.92 Million | CN¥96.49 Million | ▲ +116.5% |
| 2015 | 0.88x | CN¥40.47 Million | CN¥46.11 Million | CN¥40.47 Million | ▼ -16.8% |
| 2014 | 1.06x | CN¥31.73 Million | CN¥30.07 Million | CN¥31.73 Million | ▼ 0.0% |
| 2013 | 1.06x | CN¥34.35 Million | CN¥32.54 Million | CN¥34.35 Million | ▼ -93.1% |
| 2012 | 15.20x | CN¥41.04 Million | CN¥2.70 Million | CN¥41.04 Million | — |